Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
17.80
-0.15 (-0.84%)
May 30, 2025, 3:04 PM CST
Shandong Sito Bio-technology Company Description
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates.
Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione.
The company was founded in 2002 and is based in Heze City, China.
Shandong Sito Bio-technology Co., Ltd.
Country | China |
Founded | 2002 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 959 |
CEO | Lianbiao Jin |
Contact Details
Address: South section of East Outer Ring Road, Heze City, 274100 China | |
Phone | 86 53 0226 3536 |
Website | sitobiotech.com |
Stock Details
Ticker Symbol | 300583 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100002F36 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Lianbiao Jin | General Manager |
Fuwen Li | Chief Financial Officer |
Lu Li | Deputy GM, Board Secretary and Director |
Yong Hong Wang | Head of Accounting |